Yozma

  • About

    • Overview

    • Yozma

    • The Global Offices

    • Success Stories

  • Investment

    • Strategy

    • A Value Added Investor

    • Value Added Investments

  • Portfolio

  • Team

  • News

  • Contact

  • Main
  • News

News

  • Admin
  • Jun 01 2022

[In the News]

Todos Medical says dietary supplement Tollovid has beneficial effect in long COVID case study after 26 days

https://www.proactiveinvestors.com/companies/news/983880/todos-medical-says-dietary-supplement-tollovid-has-beneficial-effect-in-long-covid-case-study-after-26-days-983880.html
Previous
Nanox begins producing digital X-ray chips in Korea Apr 06 2022
Next
UltraSight Receives CE Mark for Novel Cardiac AI Technology Aug 25 2022
List

Please enter a prompt

Yozma
Family Site
  • YOZMA GROUP ASIA
  • YOZMA GROUP KOREA
ⓒ 2021 All Rights Reserved.
Yozma Address
9F, S&C Tower, 457 Bongeunsa-ro, Gangnam-gu, Seoul 06096, Republic of Korea
Email
orli@yozma.com
  • Privacy Policy
  • Terms & Conditions
  • Cookie Policy
ⓒ 2021 All Rights Reserved.